Extensive Trial Monitoring Confirms Evrysdi Does Not Damage Vision & The Series "Boy Meets World"
Dec 09, 2020, 12:00 AM
SMA News Today’s multimedia associate, Price Wooldridge, discusses how extensive trial monitoring confirms Evrysdi does not damage vision in children or adults with Spinal Muscular Atrophy (SMA).
SMA News Today’s Forums Director, Kevin Schaefer, talks about how the series “Boy Meets World” impacted him, and the correlation between creativity and SMA.
================================
To learn more about Evrysdi, please visit www.ApprovedForSMA.com
================================
To take part in our ongoing discussions regarding SMA, please visit www.smanewstoday.com/forums
================================
For the most up-to-date information regarding SMA, please visit www.smanewstoday.com